Research led by Michal Bassani-Sternberg of the Ludwig Lausanne branch holds great promise for the discovery of previously unknown tumor antigens for cancer immunotherapy.
This study is published in Nature Communications.
First author: Chloe Chang (post-doctoral fellow) of the Bassani Lab.